Evidence map›Paper›PMID 22465051›Full record

ReviewNeuroscience and biobehavioral reviews2012

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Patricia J Allen

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01175616 phase4withdrawnnot on this map

Creatine Augmentation in Female & Male Veterans With Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder

TypeinterventionalSponsorUniversity of UtahRan2012 to 2014Enrolled0ConditionsMajor Depressive DisorderArmsCreatine
NCT07580846 recruitingnot on this mapstarted 2026, after this paper: background citation

AssessmenT of thE Adherence of Nutritional Supplementation With Creatine Formula in Estrogen-Depleted Adult Women: Prospective Clinical Investigation

TypeobservationalSponsorMargan BiotechRan2026 to 2026Enrolled100ConditionsMenopause, Estrogen Deficiency
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. On-farm dietary supplementation of black seed (Frontiers in veterinary science · 2025
    Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Patricia J AllenDepartment of Psychology, Tufts University, Psychology Building, 490 Boston Ave., Medford, MA 02155, USA. patricia.allen@tufts.edu
Tufts University · US

Funding

Mechanisms Underlying Sex-Specific Effects of Creatine Supplementation on DepressF31AT006292 · NCCIH · TUFTS UNIVERSITY MEDFORD · PI ALLEN, PATRICIA JOAN · 2010 to 2011
$85k
NCCIH NIH HHS F31 AT006292NCCIH NIH HHS F31AT006292
6 · The paper itself

Abstract

Athletes, body builders, and military personnel use dietary creatine as an ergogenic aid to boost physical performance in sports involving short bursts of high-intensity muscle activity. Lesser known is the essential role creatine, a natural regulator of energy homeostasis, plays in brain function and development. Creatine supplementation has shown promise as a safe, effective, and tolerable adjunct to medication for the treatment of brain-related disorders linked with dysfunctional energy metabolism, such as Huntington's Disease and Parkinson's Disease. Impairments in creatine metabolism have also been implicated in the pathogenesis of psychiatric disorders, leaving clinicians, researchers and patients alike wondering if dietary creatine has therapeutic value for treating mental illness. The present review summarizes the neurobiology of the creatine-phosphocreatine circuit and its relation to psychological stress, schizophrenia, mood and anxiety disorders. While present knowledge of the role of creatine in cognitive and emotional processing is in its infancy, further research on this endogenous metabolite has the potential to advance our understanding of the biological bases of psychopathology and improve current therapeutic strategies.

Indexed as

BrainCognitionCreatineDietary SupplementsEmotionsEnergy MetabolismHumansMental DisordersModels, BiologicalCreatine

Identifiers

PMID22465051
PMCPMC3340488
OpenAlexW2127632956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.